© ACCESSWIRE
12.01.2026
REVB
LISTED
NASDAQ
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, CA / ACCESS Newswire / January 12, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced that on January 8, 2026, the Compensation Committee of Revelation's Board of Directors approved an in...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
TNG
LISTED
EURONEXT
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2025
News Preview
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA
as of December 31, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
ALSAF
LISTED
EURONEXT
SAFE GROUP NOMME CYRIL GONCALVES AU POSTE DE DIRECTEUR ADMINISTRATIF ET FINANCIER
News Preview
SAFE GROUP NOMME CYRIL GONCALVES AU POSTE DE DIRECTEUR ADMINISTRATIF ET FINANCIER...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
12.01.2026
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
12.01.2026
ATRC
LISTED
NASDAQ
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
News Preview
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced preliminary financial results for the fourth quarter and full year 2025 and provided 2026 financial guidance.
Preliminary, unaudited rev...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
BIIB
LISTED
NASDAQ
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
News Preview
CAMBRIDGE, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the European Commission (EC) has granted marketing authorization for a high dose regimen of SPINRAZA® (nusinersen) which is comprised of 50 mg/5 mL and 28 mg/5 mL doses for the treatment of 5q spinal muscular atrophy (SMA). 5q SMA is the most common for...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
NTRA
LISTED
NASDAQ
Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
News Preview
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a new collaboration with NVIDIA to accelerate the development of Natera’s multimodal AI foundation model platform and expand applications across precision medicine.
Under the collaboration, Natera will integrate its unique longitudinal an...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
TLT
LISTED
TSX
Canadian Investment Regulatory Organization Trade Resumption - TLT
News Preview
VANCOUVER, BC, Jan. 12, 2026 /CNW/ - Trading resumes in:
Company: Theralase Technologies Inc.TSX-Venture Symbol: TLTAll Issues: YesResumption (ET): 10:00CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is t...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
ATEC
LISTED
NASDAQ
ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion
News Preview
ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic AlignmentTheradaptive Initiates Series B to Advance Proprietary Protein-Engineering TechnologyCARLSBAD, Calif. and FREDERICK, Md., Jan. 12, 2026 /PRNewswire/ -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing spine...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
BBIO
LISTED
NASDAQ
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
- Preliminary unaudited Q4 and Full Year 2025 net Attruby® product revenue of $146.0 million and $362.4 million, respectively...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
TXG
LISTED
NASDAQ
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
News Preview
Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
12.01.2026
TXG
LISTED
NASDAQ
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
News Preview
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to power precision oncology10x also plans to establish a CLIA-certified laboratory to enable development of future innovative diagnostic testsPLEASANTON, C...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
HITC
LISTED
OTC
SafeSpace Global Corporation (OTCID: SSGC) Issues CEO Letter to Shareholders
News Preview
Knoxville, TN, Jan. 12, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC), a leading AI technology company delivering multimodal safety solutions across education, healthcare, transportation, and correctional facilities, today announced that Chief Executive Officer Scott M. Boruff has issued a comprehensive Letter to Shareholder...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
ATEC
LISTED
NASDAQ
ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook
News Preview
Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026.
Preliminary, Unaudited F...
Themefolio
Profiler
Peergroup
© EQS Newswire
12.01.2026
SDZ
LISTED
XWSX
Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity
News Preview
Sandoz Group AG
/ Key word(s): Conference
Sandoz CEO, speaking at 44th Annual J.P. Morgan Healthcare Conference, will outline plans to capitalize on unprecedented ’golden decade’ of affordable medicines opportunity 12.01.2026 / 15:00 CET/CEST
After consistently delivering on commitments in first two years as standalone compan......
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
TXG
LISTED
NASDAQ
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
News Preview
Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next generation of immunotherapies and vaccine discovery PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single ce...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
CODX
LISTED
OTC
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships
News Preview
SALT LAKE CITY, Jan. 12, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoSara Diagnostics Pvt. Ltd. ("CoSara"), the Indian joint venture between Co-Dx and Ambalal Sarabhai E...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
DHR
LISTED
NYSE
Danaher CEO to Comment on Financial Performance
News Preview
WASHINGTON, Jan. 12, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2025 performance in a presentation at the J.P. Morgan Healthcare Conference at 11:15 a.m. PT.
For the fourth quarter 2025, estimat...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
MDT
LISTED
NYSE
Medtronic Diabetes announces FDA clearance for MiniMed Go™ Smart MDI system featuring Instinct sensor made by Abbott
News Preview
MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily injectionsGALWAY, Ireland, Jan. 12, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Dru...
Themefolio
Profiler
Peergroup
© Newsfile
12.01.2026
PWR
LISTED
CSE
Captiva Verde Wellness Corp. Announces Opening of Atmospheric Water Station in Florida
News Preview
Coquitlam, British Columbia--(Newsfile Corp. - January 12, 2026) - Captiva Verde Wellness Corp. (CSE: PWR) (OTC Pink: CPIVF) (the "Company or Captiva") announces that it will co-host a significant atmospheric water station ribbon cutting ceremony on January 30, 2026 in Florida. Further details on the other institutional co-hosts and the location w...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
MASI
LISTED
NASDAQ
Masimo Announces Select Preliminary 2025 Financial Results
News Preview
Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended January 3, 2026.
Preliminary Fourth Quarter 2025 Financial Results:
•
Revenue is expected to be approximately $411 million, representing approximately 12% growth on a reported basis and 11% g...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
ABCL
LISTED
NASDAQ
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause
News Preview
AbCellera (Nasdaq: ABCL) today announced that the first patients have been dosed in the Phase 2 portion of its ongoing Phase 1/2 clinical trial for ABCL635. ABCL635 is a potential first-in-class non-hormonal treatment for moderate-to-severe vasomotor symptoms (VMS) associated with menopause.
The transition to Phase 2 follows an interim review of...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
HUM
LISTED
NYSE
CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program
News Preview
CenterWell Pharmacy, a leader in specialty pharmacy and home delivery pharmacy, today announced that it will dispense Eli Lilly and Company (Lilly) obesity management medications as part of a new, employer-focused program administered by independent third-party administrators.
CenterWell Pharmacy will serve as a dispensing pharmacy available to...
Themefolio
Profiler
Peergroup
© EQS Newswire
12.01.2026
EUZ
LISTED
XETR
Eckert & Ziegler präsentiert auf der 44. Annual J.P. Morgan Healthcare Conference
News Preview
Berlin, 12. Januar 2026. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) wird an der 44. Annual J.P. Morgan Healthcare Conference am Mittwoch, den 14. Januar 2026, im Westin St. Francis in San Francisco, CA, USA, teilnehmen. Dr. Harald Hasselmann, Vorstandsvorsitzender der Eckert & Ziegler SE, wird das Unternehmen um 17:15 PST präsentie......
Themefolio
Profiler
Peergroup
© EQS Newswire
12.01.2026
EUZ
LISTED
XETR
Eckert & Ziegler to Participate in the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Berlin, 12 January 2026. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, 14 January 2026, at the Westin St. Francis in San Francisco, CA, USA. Dr Harald Hasselmann, CEO of Eckert & Ziegler SE, will present the company at 17:15 PST.
The presentation will be a......
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
PTCT
LISTED
NASDAQ
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
News Preview
– Strong Sephience™ (sepiapterin) launch continues with unaudited Q4 global revenue of $92.5M –– Unaudited 2025 total product and royalty revenue of approximately $823M, exceeding guidance –– 2026 product revenue guidance of $700 – 800M, representing 19 – 36% year-over-year growth –– Strong cash position of approximately $1.94B as of December 31 –...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
INGN
LISTED
NASDAQ
Inogen Announces Preliminary Revenue Results for Fourth Quarter and Full-Year 2025
News Preview
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, unaudited revenue results for the quarter and year ended December 31, 2025.
The Company estimates preliminary, unaudited total revenue in the fourth quarter of 2025 to be approximately $...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
TEM
LISTED
NASDAQ
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
News Preview
Tempus, a leader in artificial intelligence and precision medicine, and NYU Langone Health, one of the nation’s premier academic medical centers, today announced a multi-year strategic collaboration aimed at transforming cancer care through advanced molecular profiling and data-driven insights. The collaboration will support NYU Langone Health’s C...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
IBRX
LISTED
NASDAQ
NantWorks and ImmunityBio Announce Inaugural U.S.-Saudi Biotech Alliance Summit to Advance Immunotherapy 2.0 and Global Health Security
News Preview
NantWorks, LLC, and ImmunityBio, Inc. (NASDAQ: IBRX), today announced the inaugural U.S.-Saudi Biotech Alliance Summit, to be held in conjunction with the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026, from 9:00 am to 5:30 pm Pacific Time.
Convened by NantWorks, the Summit brings together national...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
TKOMF
LISTED
OTC
Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today provided its preliminary and unaudited estimates for full-year 2025 net product sales, year-end cash balance, corporate updates and full-year 2026 outlook.
“2025 was an excellent year for Mirum, reflecting the strength and scalability of our purpose-built rare dise...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
SDGR
LISTED
NASDAQ
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
News Preview
Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its physics+AI computational platform and serving as a global leader in computational molecular discovery.
“In 2025, we witnessed the continued impact of...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
PACB
LISTED
NASDAQ
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
News Preview
The planned collaboration highlights the role of complete genome resolution in scaling n-of-1 therapeutic models The planned collaboration highlights the role of complete genome resolution in scaling n-of-1 therapeutic models...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
PCSA
LISTED
NASDAQ
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
News Preview
VERO BEACH, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that George Ng, Chief Executive Officer, and Patrick Lin, Chief Business & Strategy Officer and Founder, will attend the 44th Annual J....
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
TMDX
LISTED
NASDAQ
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
News Preview
ANDOVER, Mass., Jan. 12, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a global leader in organ transplant technologies and services, today announced the signing of a long-term lease for its new global headquarters at Assembly Innovation Park in Somerville, as well as the acquisition of the adjacent land parcel to cr...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
2269
LISTED
HKSE
WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing
News Preview
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform designed to transform bioprocess development and manufacturing. By combining advanced real-time process monitor...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
RIGL
LISTED
NASDAQ
Rigel Provides Business Update and 2026 Outlook
News Preview
Preliminary fourth quarter 2025 total revenue of approximately $69.8 million, including net product sales of $65.4 million and contract revenues of $4.4 millionIn the dose escalation phase of the Phase 1b study of R289 in patients with lower-risk MDS, R289 continues to be generally well tolerated. RBC-TI was achieved by 33% (6/18) of evaluable tra...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
AVTR
LISTED
NYSE
Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026
News Preview
RADNOR, Pa., Jan. 12, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its fourth quarter and full year 2025 financial results before the market opens on Wednesday, February, 11, a...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
2171
LISTED
HKSE
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
News Preview
SHANGHAI, PHILADELPHIA and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, and Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
PACB
LISTED
NASDAQ
PacBio Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
News Preview
Q4 2025 revenue growth of 14% year-over-year, driven by strong Revio and Vega shipments and record consumables revenue Q4 2025 revenue growth of 14% year-over-year, driven by strong Revio and Vega shipments and record consumables revenue...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
PACB
LISTED
NASDAQ
PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)
News Preview
Trios from 200 families who have lost a child to SUDC to be sequenced on PacBio’s Revio system with SPRQ-Nx chemistry, enabling increased diagnostic yield for grieving families Trios from 200 families who have lost a child to SUDC to be sequenced on PacBio’s Revio system with SPRQ-Nx chemistry, enabling increased diagnostic yield for grieving famil...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
TTRX
LISTED
NASDAQ
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Turn Therapeutics, Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted inflammatory and immunological therapies for dermatologic and infectious diseases, today announced corporate, financial, and pipeline updates in advance of its participation at the 2026 J.P. Morgan Healthcare Conference, taking place January 12–15, 2...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
BLFS
LISTED
NASDAQ
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations
News Preview
Fourth quarter unaudited revenue from continuing operations of $24.8 million increased 20% from the prior year fourth quarterFull year unaudited revenue from continuing operations of $96.2 million exceeded the high end of the previously raised guidance range for FY2025BOTHELL, Wash., Jan. 12, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: B...
Themefolio
Profiler
Peergroup
© Newsfile
12.01.2026
OSTX
LISTED
XASE
OS Therapies Enters into Warrant Inducement Agreements
News Preview
$7.53M gross proceeds raised from pre-existing investors, providing capital runway into 2027All nine investors that were offered agreed to participateNet proceeds to fund OST-HER2 regulatory approval submissions, commercial preparation activities and preparations for OS Animal Health proposed spinoff transactionNew York, New York--(Newsfile Corp. -...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
BFLY
LISTED
NYSE
Butterfly Network Reports Preliminary, Unaudited Fourth Quarter 2025 Revenue Growth of at least 17% Year over Year
News Preview
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”, “the company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2025 of at least 17% year over year.
Joseph DeVivo, Butte...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
GALD
LISTED
XWSX
Galderma announces the authorization of NEMLUVIO® (nemolizumab) for atopic dermatitis and prurigo nodularis in Canada
News Preview
NEMLUVIO is the first authorized monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31.1 IL-31 is a neuroimmune cytokine that drives itch and is involved in inflammation and skin barrier dysfunction in both atopic dermatitis and prurigo nodularis 2-5NEMLUVIO is now authorized for sale by Health Canad...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
PGEN
LISTED
NASDAQ
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS in August 2025, the first-and-only FDA-approved treatment for adults with RRP PAPZIMEOS commercialization is well underway and PAPZIMEOS is being prescribed nationwide, with patients actively receiving treatmentPAPZIMEOS patient hub enrollment has surpassed 200 r...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
OBIO
LISTED
NASDAQ
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
News Preview
NEW HOPE, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that it expects to receive up to $21 million in cash proceeds in connectio...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
BIOA
LISTED
NASDAQ
BioAge Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-in-Class hsCRP Reduction in Participants with Elevated Cardiovascular Risk
News Preview
First BGE-102 MAD cohort completed in obese individuals with elevated hsCRP receiving 120 mg QD; demonstrated rapid and profound reduction in inflammatory markers...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
SIBN
LISTED
NASDAQ
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
News Preview
Fiscal Year 2025 worldwide revenue of $200.8 to $200.9 million, representing growth of ~20% Fiscal Year 2025 worldwide revenue of $200.8 to $200.9 million, representing growth of ~20%...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.01.2026
NSPR
LISTED
NASDAQ
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
News Preview
The CGuard® Prime Carotid Stent System demonstrated the lowest 30-day and 1-year primary endpoint major adverse event rates of any pivotal study of carotid stenting (CAS)...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
6446
LISTED
TAI
PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia
News Preview
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, today announced positive topline results from its Phase 2b EXCEED-ET clinical trial of ropegint...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
BAYN
LISTED
XETR
Bayer to Expand Into Molecular Imaging With Acquisition of Innovative Pan-Amyloid Radiotracers From Attralus
News Preview
Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for systemic amyloidosis, today announced that the companies have entered into definitive agreements for Bayer to acquire AT-01 (124-Iodine-evuzamitide) and AT-...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
ESTA
LISTED
NASDAQ
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced preliminary unaudited financial results for the three months and fiscal year ended December 31, 2025.
Establishment Labs’ preliminary unaudit...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
ATRA
LISTED
NASDAQ
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
News Preview
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
TWST
LISTED
NASDAQ
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced preliminary, unaudited revenue for the first quarter of fiscal 2026 ended December 31, 2025.
Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com to view the fiscal 2026...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
KRMD
LISTED
NASDAQ
KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow
News Preview
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced preliminary unaudited results for the fourth quarter and full year ended Decembe...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
VIR
LISTED
NASDAQ
Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones
News Preview
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving the combination therapy of tobevibart, an investigational neutralizing monoclonal antibody (mAb), and elebsiran, an investigational small interfering...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2026
NUVB
LISTED
NYSE
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
News Preview
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue for IBTROZI® (taletrectinib) and provided a 2026 outlook ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
